| Literature DB >> 25780475 |
Jean-Sebastien Pelletier1, Richdeep S Gill1, Sayf Gazala1, Shahzeer Karmali2.
Abstract
Gastric gastrointestinal stromal tumors (GISTs) are the most common sarcoma of the gastrointestinal tract, and surgical resection is the primary treatment of early disease. Limited data exist concerning laparoscopic resections of these neoplasms. This systematic review was designed to evaluate the literature comparing laparoscopic and open surgical resection of gastric GISTs and to assess the effectiveness and safety of this minimally invasive technique. We performed a systematic search of MEDLINE, the Cochrane Library, PubMed, Embase, Scopus, Web of Science, Google Scholar, the clinical trials database and ProQuest Dissertations and Theses as well as the past 3 years of conference abstracts from the Society of American Gastrointestinal and Endoscopic Surgeons Annual Meetings. Studies comparing the open and the laparoscopic approaches to the resection of gastric GISTs were included in this systematic review. Two reviewers independently performed the screen of titles and abstracts, the full manuscript review, the data extraction and the risk of bias assessment. A quantitative analysis was performed. Of the 189 studies identified, seven studies were included. The laparoscopic approach was associated with a significantly lower length of hospital stay (3.82 days (2.14 - 5.49)). There was no observed difference in operative time, adverse events, estimated blood loss, overall survival and recurrence rates. This study supports that laparoscopic resection is safe and effective for gastric GISTs and is associated with a significantly lower length of hospital stay. Further trials are needed for cost analysis and to rigorously assess oncologic outcomes.Entities:
Keywords: GIST; Laparoscopy; Meta-analysis; Resection; Review; Stomach; Surgery
Year: 2015 PMID: 25780475 PMCID: PMC4356087 DOI: 10.14740/jocmr1547w
Source DB: PubMed Journal: J Clin Med Res ISSN: 1918-3003
Medline Search Strategy
| Concept 1 | Concept 2 | Concept 3 | Concept 4 | Results | |||
|---|---|---|---|---|---|---|---|
| laparoscop* or exp laparoscopy or telesurg* or “tele surg*” or minimal* | AND | (usual or wedge or traditional or standard* or open or invasive or normal or routine) adj3 (resect* or surger* or surgi*) | AND | GIST or exp gastrointestinal stromal tumors/or (gastrointestinal stromal adj2 (neoplasm* or tumo*)).mp. | AND | gastri* or stomach | 81 |
Limit to English language.
Figure 1Systematic review PRISMA flow diagram.
Study Characteristics
| Authors | Year | Journal name | Article name | Design | Outcomes | Follow-up period (months) | |
|---|---|---|---|---|---|---|---|
| L | O | ||||||
| Catena et al | 2008 [ | Journal of Gastrointestinal Surgery | Laparoscopic treatment of gastric GIST: report of 21 cases and literature’s review | RCS | LOS | Mean: 35 | Mean: 91 |
| Nishimura et al | 2007 [ | Surgical Endoscopy | Surgical strategy for gastric gastrointestinal stromal tumors: laparoscopic vs. open resection | RCS | OR time | Median: 19 | Median: 31 |
| Karakousis et al | 2011 [ | Annals of Surgical Oncology | Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison | CCS | LOS | Median: 28 | Median: 43 |
| Matthews et al | 2002 [ | Surgical Endoscopy | Laparoscopic vs. open resection of gastric stromal tumors | RCS | LOS | Mean: 20 | Mean: 18 |
| Pitsinis et al | 2007 [ | Hepato-Gastroenterology | Single center experience of laparoscopic vs. open resection for gastrointestinal stromal tumors of the stomach | RCS | LOS | Median: 9 | Median: 9 |
| Silberhumer et al | 2009 [ | Journal of Gastrointestinal Surgery | Surgery for gastrointestinal stromal tumors of the stomach | RCS | LOS | Mean: 30 | Mean: 41 |
| Wu et al | 2010 [ | Journal of Laparoscopic and Advanced Surgical Techniques | Gasless laparoscopy-assisted versus open resection for gastrointestinal stromal tumors of the upper stomach: preliminary results | RCS | LOS | N/A | N/A |
RCS: retrospective cohort study; CCS: case-control study; BMI: body mass index; LOS: length of stay; OR time: operating room time; EBL: estimated blood loss; Med: median; N/A: not available; L: laparoscopic group; O: open group.
Patient Characteristics of Included Trials
| Authors, year | Number of patients | Age | BMI | Tumor size | Procedures performed | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| L | O | L | O | L | O | L | O | L | O | |
| Catena et al, 2008 [ | 21 | 25 | 50.1 | 54.6 | N/A | N/A | 4.5 | 6.2 | 86% W; 14% DG | 50% W; 33% DG; 17% PG |
| Nishimura et al, 2007 [ | 39 | 28 | 62t | 63t | N/A | N/A | 3.8t | 4.2t | 100% W | 68% W; 4% DG; 18% PG; 11% TG |
| Karakousis et al, 2011 [ | 40 | 40 | 67t | 70t | N/A | N/A | 3.6t | 4.3t | 100% W | 95% W; 5% DG |
| Matthews et al, 2002 [ | 21 | 12 | 53.9 | 50.5 | N/A | N/A | 4.5 | 4.9 | 86% W; 14% DG | 50% W; 33% DG; 17% PG |
| Pitsinis et al, 2007 [ | 6 | 7 | 70t | 68t | N/A | N/A | 5t | 11.5t | N/A | N/A |
| Silberhumer et al, 2009 [ | 22 | 41 | 61.3 | 62.5 | N/A | N/A | 3.5 | 5.8 | 100% W | 78% W; 12% DG; 10% TG |
| Wu et al, 2010[ | 15 | 13 | 61.6 | 60.7 | 23.4 | 22.7 | 2.6 | 2.5 | 100% W | 100% W |
Values expressed as mean unless otherwise indicated. t: median value. L: laparoscopic group; O: open group; N/A: not available; W: wedge resection; DG: distal gastrectomy; PG: proximal gastrectomy; TG: total gastrectomy.
Newcastle-Ottawa Scale for Risk of Bias
| Study ID | Catena et al, 2008 [ | Nishimura et al, 2007 [ | Karakousis et al, 2011 [ | Matthews et al, 2002 [ | Pitisinis et al, 2007 [ | Silberhumer et al, 2009 [ | Wu et al, 2012 [ |
|---|---|---|---|---|---|---|---|
| Study design | Retrospective cohort | Retrospective cohort | Case-control study | Retrospective cohort | Retrospective cohort | Retrospective cohort | Retrospective cohort |
| Selection | **** | **** | **** | **** | **** | **** | **** |
| Comparability | * | ||||||
| Outcome/exposure | *** | *** | *** | *** | *** | *** | *** |
Figure 2Forest plot depicting the mean differences in length of hospital stay (days) in the included studies, if reported.
Figure 3Forest plot depicting the mean differences in length of operative time (min) in the included studies, if reported.
Figure 4Forest plot depicting the risk ratio of total adverse events in the included studies, if reported.
Figure 5Forest plot depicting the mean differences in the estimated blood loss (mL) in the included studies, if reported.
Figure 6Forest plot depicting the risk ratio for recurrence in the included studies, if reported.
Figure 7Forest plot depicting the risk ratio for overall survival in the included studies, if reported.